Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravits, J.
Right arrow Articles by Jorg, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ravits, J.
Right arrow Articles by Jorg, C.
Related Collections
Right arrow Anterior nerve cell disease
Right arrow Amyotrophic lateral sclerosis
Right arrowRelated Article
NEUROLOGY 2007;68:1571-1575
© 2007 American Academy of Neurology

Focality of upper and lower motor neuron degeneration at the clinical onset of ALS

John Ravits, MD, FAAN, Piper Paul, RN and Cathy Jorg, BA

From the Sections of Neurology (J.R., P.P.), Neuro-Rehabilitation (C.J.), and the ALS Clinic at Virginia Mason (J.R., P.P., C.J.), Virginia Mason Medical Center, Seattle; and Neurogenomics Laboratory (J.R.), Benaroya Research Institute at Virginia Mason, Seattle, WA.

Address correspondence and reprint requests to Dr. John Ravits, Neurogenomics Laboratory, Benaroya Research Institute at Virginia Mason, 1201 Ninth Avenue, Seattle, WA 98101 john.ravits{at}vmmc.org

Objective: To localize and analyze the anatomic distribution of upper motor neuron (UMN) and lower motor neuron (LMN) loss in patients with ALS early in their disease when motor manifestations were still relatively focal using clinical examination signs.

Methods: We reviewed records of 100 patients with ALS who were evaluated when the diagnosis was first established or suspected. From the patient history, we ascertained the body region of first symptoms and the time course. From the physical examination, we separately graded severity of UMN and LMN signs in each body region, indexed these to the body region of first symptoms, and sorted and analyzed the data.

Results: Motor manifestations began in one body region in 98% of patients. UMN and LMN signs were both maximal in these same body regions, but they were independent of each other in severity and their outward distribution, which conformed to neuronal anatomy. The outward distribution of both UMN and LMN signs seemed more directed to caudal body regions than to rostral ones.

Conclusions: Motor neuron degeneration in ALS is a focal process at both upper and lower motor neuron levels of the motor system. At each level, it begins corresponding to the same peripheral body region and then advances contiguously and separately to summate over time.

See also page 1576

Supplemental dataat www.neurology.org

Supported by grants from the National Institute of Neurological Diseases and Stroke (NS051738), Juniper Foundation, Moyer Foundation, and Benaroya Foundation.

Disclosure: The authors report no conflicts of interest.

Presented at the 17th International Symposium on ALS/MND, November 30, 2006, Yokohama, Japan.

Received June 23, 2006. Accepted in final form December 7, 2006.


Related Article

Implications of ALS focality: Rostral–caudal distribution of lower motor neuron loss postmortem
John Ravits, Patrick Laurie, Yuxin Fan, and Dan H. Moore
Neurology 2007 68: 1576-1582. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.